Treatment of endometriosis-related pain: Options and outcomes

Research output: Contribution to journalArticle

Abstract

Endometriosis-associated pain represents a challenge for both the patient and the health care provider since it is often difficult to design treatment strategies resulting in improvement of the symptoms. The association between endometriosis stage and severity of pelvic symptoms is limited. Surgery is generally considered the first line treatment in women affected, at least in those who have not been previously operated, but there are several situations in which medical treatments are useful. Given their good tolerability, minor metabolic effects and low cost, progestogens with or without the addition of estrogens, can be considered the drugs of choice and are currently the only safe and inexpensive alternative to surgery. Progestogens are effective in controlling pain symptoms in approximately three of four women with endometriosis. There is little or no difference in the effectiveness of GnRH agonist and add-back treatment in comparison with other medical treatments for endometriosis while the surgical interruption of pelvic nerve pathways entail some clinically relevant risks.

Original languageEnglish
Pages (from-to)455-465
Number of pages11
JournalFrontiers in Bioscience - Elite
Volume1 E
Issue number2
Publication statusPublished - Jun 1 2009

Fingerprint

Progestins
Endometriosis
Surgery
Pain
Health care
Gonadotropin-Releasing Hormone
Estrogens
Therapeutics
Pharmaceutical Preparations
Costs
Health Personnel
Patient Care
Costs and Cost Analysis

Keywords

  • Endometriosis
  • Medical therapy
  • Pelvic pain
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Treatment of endometriosis-related pain : Options and outcomes. / Somigliana, Edgardo; Vigano, Paola; Barbara, Giussy; Vercellini, Paolo.

In: Frontiers in Bioscience - Elite, Vol. 1 E, No. 2, 01.06.2009, p. 455-465.

Research output: Contribution to journalArticle

@article{c7c5b7b7214c4e5f8e1e9c4c1cdb7b59,
title = "Treatment of endometriosis-related pain: Options and outcomes",
abstract = "Endometriosis-associated pain represents a challenge for both the patient and the health care provider since it is often difficult to design treatment strategies resulting in improvement of the symptoms. The association between endometriosis stage and severity of pelvic symptoms is limited. Surgery is generally considered the first line treatment in women affected, at least in those who have not been previously operated, but there are several situations in which medical treatments are useful. Given their good tolerability, minor metabolic effects and low cost, progestogens with or without the addition of estrogens, can be considered the drugs of choice and are currently the only safe and inexpensive alternative to surgery. Progestogens are effective in controlling pain symptoms in approximately three of four women with endometriosis. There is little or no difference in the effectiveness of GnRH agonist and add-back treatment in comparison with other medical treatments for endometriosis while the surgical interruption of pelvic nerve pathways entail some clinically relevant risks.",
keywords = "Endometriosis, Medical therapy, Pelvic pain, Review",
author = "Edgardo Somigliana and Paola Vigano and Giussy Barbara and Paolo Vercellini",
year = "2009",
month = "6",
day = "1",
language = "English",
volume = "1 E",
pages = "455--465",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "2",

}

TY - JOUR

T1 - Treatment of endometriosis-related pain

T2 - Options and outcomes

AU - Somigliana, Edgardo

AU - Vigano, Paola

AU - Barbara, Giussy

AU - Vercellini, Paolo

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Endometriosis-associated pain represents a challenge for both the patient and the health care provider since it is often difficult to design treatment strategies resulting in improvement of the symptoms. The association between endometriosis stage and severity of pelvic symptoms is limited. Surgery is generally considered the first line treatment in women affected, at least in those who have not been previously operated, but there are several situations in which medical treatments are useful. Given their good tolerability, minor metabolic effects and low cost, progestogens with or without the addition of estrogens, can be considered the drugs of choice and are currently the only safe and inexpensive alternative to surgery. Progestogens are effective in controlling pain symptoms in approximately three of four women with endometriosis. There is little or no difference in the effectiveness of GnRH agonist and add-back treatment in comparison with other medical treatments for endometriosis while the surgical interruption of pelvic nerve pathways entail some clinically relevant risks.

AB - Endometriosis-associated pain represents a challenge for both the patient and the health care provider since it is often difficult to design treatment strategies resulting in improvement of the symptoms. The association between endometriosis stage and severity of pelvic symptoms is limited. Surgery is generally considered the first line treatment in women affected, at least in those who have not been previously operated, but there are several situations in which medical treatments are useful. Given their good tolerability, minor metabolic effects and low cost, progestogens with or without the addition of estrogens, can be considered the drugs of choice and are currently the only safe and inexpensive alternative to surgery. Progestogens are effective in controlling pain symptoms in approximately three of four women with endometriosis. There is little or no difference in the effectiveness of GnRH agonist and add-back treatment in comparison with other medical treatments for endometriosis while the surgical interruption of pelvic nerve pathways entail some clinically relevant risks.

KW - Endometriosis

KW - Medical therapy

KW - Pelvic pain

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=70449650621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449650621&partnerID=8YFLogxK

M3 - Article

C2 - 19482659

AN - SCOPUS:70449650621

VL - 1 E

SP - 455

EP - 465

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 2

ER -